SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
Health Status and Quality of Life in Patients With Early Stage Hodgkin's Disease: A Companion Study to SWOG-9133
Sponsor: Cancer and Leukemia Group B
A observational or N/A phase clinical study on Lymphoma and Psychosocial Effects of Cancer and Its Treatment, this trial is completed. The trial is conducted by Cancer and Leukemia Group B and has accumulated 8 data snapshots since 1994. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — May 2023 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Apr 1994
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer and Leukemia Group B
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Buffalo, United States, Columbia, United States, Iowa City, United States, Memphis, United States, New York, United States, Providence, United States, St Louis, United States, Syracuse, United States, Washington D.C., United States, Winston-Salem, United States and 1 more location